| Bioactivity | LL-37 FKR is the C-terminal fragment of LL-37. LL-37 FKR plays an important role in antibacterial performance[1][2]. |
| Name | LL-37 FKR |
| CAS | 913736-94-4 |
| Sequence | Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser |
| Shortening | FKRIVQRIKDFLRNLVPRTES |
| Formula | C118H199N37O30 |
| Molar Mass | 2616.07 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sigurdardottir T, et al. In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37. Antimicrob Agents Chemother. 2006 Sep;50(9):2983-9. [2]. Ringstad L, et al. Effects of single amino acid substitutions on peptide interaction with lipid membranes and bacteria–variants of GKE21, an internal sequence from human LL-37[J]. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2010, 354(1-3): 65-71. |